Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3.97% is 39% below its 5-year average of 6.55%, around the middle of its 5-year range (-25.35%–38.40%).
49.49% below its 12-month average of 7.86%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.10%.
NET PROFIT MARGIN
3.97%
NET PROFIT MARGIN AVG TTM
7.86%
NET PROFIT MARGIN AVG 3Y
19.69%
NET PROFIT MARGIN AVG 5Y
6.55%
NET PROFIT MARGIN AVG 10Y
-4.74%
NET PROFIT MARGIN AVG 15Y
-8.41%
NET PROFIT MARGIN AVG 20Y
-8.60%
CURRENT VS TTM AVG
-49.49%
CURRENT VS 3Y AVG
-79.84%
CURRENT VS 5Y AVG
-39.40%
CURRENT VS 10Y AVG
+183.68%
CURRENT VS 15Y AVG
+147.22%
CURRENT VS 20Y AVG
+146.15%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$7.23B
Net Profit Margin
-64.64%
TTM Avg
-52.37%
3Y Avg
-49.29%
5Y Avg
-43.60%
Market Cap
$6.65B
Net Profit Margin
10.60%
TTM Avg
11.45%
3Y Avg
11.66%
5Y Avg
12.42%
Market Cap
$6.65B
Net Profit Margin
-7585.86%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.55B
Net Profit Margin
-236.95%
TTM Avg
-945.70%
3Y Avg
-3296.24%
5Y Avg
-3620.73%
Market Cap
$6.53B
Net Profit Margin
17.69%
TTM Avg
17.76%
3Y Avg
15.93%
5Y Avg
7.17%
Market Cap
$6.52B
Net Profit Margin
-5.51%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$6.47B
Net Profit Margin
5.05%
TTM Avg
-0.89%
3Y Avg
-2.79%
5Y Avg
-1.02%
Market Cap
$7.58B
Net Profit Margin
15.15%
TTM Avg
-46.46%
3Y Avg
-43.29%
5Y Avg
-43.29%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alkermes plc (ALKS) | $6.98B | 3.97% | 7.86% | 19.69% | 6.55% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.23B | -64.64% | -52.37% | -49.29% | -43.60% |
| Chemed Corporation (CHE)vs › | $6.65B | 10.60% | 11.45% | 11.66% | 12.42% |
| Immunovant, Inc. (IMVT)vs › | $6.65B | -7585.86% | 0.00% | 0.00% | 0.00% |
| GRAIL Inc. (GRAL)vs › | $6.55B | -236.95% | -945.70% | -3296.24% | -3620.73% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | 17.69% | 17.76% | 15.93% | 7.17% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.52B | -5.51% | 7.00% | -0.29% | -8.82% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.47B | 5.05% | -0.89% | -2.79% | -1.02% |
| Hinge Health, Inc. (HNGE)vs › | $7.58B | 15.15% | -46.46% | -43.29% | -43.29% |
| HealthEquity, Inc. (HQY)vs › | $7.62B | 17.36% | 12.22% | 6.75% | 3.72% |
Operating Margin
17.2%
Net Profit Margin
4.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.10% |
| 2026-03-31 | -16.92% |
| 2025-12-31 | 12.83% |
| 2025-09-30 | 21.00% |
| 2025-06-30 | 22.30% |
| 2025-03-31 | 7.33% |
| 2024-12-31 | 34.07% |
| 2024-09-30 | 24.43% |
| 2024-06-30 | 22.89% |
| 2024-03-31 | 10.51% |
| 2023-12-31 | 29.88% |
| 2023-09-30 | 12.54% |
| 2023-06-30 | 38.40% |
| 2023-03-31 | -14.55% |
| 2022-12-31 | -9.27% |
| 2022-09-30 | -25.35% |
| 2022-06-30 | -10.91% |
| 2022-03-31 | -12.89% |
| 2021-12-31 | 0.27% |
| 2021-09-30 | -9.86% |
| 2021-06-30 | 0.78% |
| 2021-03-31 | -8.92% |
| 2020-12-31 | -15.23% |
| 2020-09-30 | -0.05% |
| 2020-06-30 | -11.89% |
| 2020-03-31 | -15.70% |
| 2019-12-31 | -1.30% |
| 2019-09-30 | -20.72% |
| 2019-06-30 | -15.00% |
| 2019-03-31 | -43.21% |
| 2018-12-31 | -3.08% |
| 2018-09-30 | -13.85% |
| 2018-06-30 | -10.72% |
| 2018-03-31 | -27.76% |
| 2017-12-31 | -3.55% |
| 2017-09-30 | -16.69% |
| 2017-06-30 | -19.65% |
| 2017-03-31 | -35.92% |
| 2016-12-31 | -9.90% |
| 2016-09-30 | -34.78% |
| 2016-06-30 | -24.18% |
| 2016-03-31 | -49.39% |
| 2015-12-31 | -42.54% |
| 2015-09-30 | -53.07% |
| 2015-06-30 | -30.46% |
| 2015-03-31 | -19.02% |
| 2014-12-31 | 17.42% |
| 2014-09-30 | -24.97% |
| 2014-06-30 | 2.43% |
| 2014-03-31 | -18.70% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | -5.55% |
| 2013-06-30 | 5.29% |
| 2013-03-31 | 1.84% |
| 2012-12-31 | 11.96% |
| 2012-09-30 | -13.48% |
| 2012-06-30 | 14.74% |
| 2012-03-31 | -48.56% |
| 2011-12-31 | -11.80% |
| 2011-09-30 | -30.92% |
| 2011-06-30 | -21.39% |
| 2011-03-31 | -25.58% |
| 2010-12-31 | -25.89% |
| 2010-09-30 | -15.57% |
| 2010-06-30 | -31.71% |
| 2010-03-31 | -36.22% |
| 2009-12-31 | -15.44% |
| 2009-09-30 | -18.08% |
| 2009-06-30 | -21.40% |
| 2009-03-31 | -30.99% |
| 2008-12-31 | 72.41% |
| 2008-09-30 | 3.59% |
| 2008-06-30 | 37.11% |
| 2008-03-31 | -29.40% |
| 2007-12-31 | 332.63% |
| 2007-09-30 | 13.14% |
| 2007-06-30 | 12.69% |
| 2007-03-31 | 5.40% |
| 2006-12-31 | 4.70% |
| 2006-09-30 | 6.09% |
| 2006-06-30 | -1.39% |
| 2006-03-31 | 8.19% |
| 2005-12-31 | 3.40% |
| 2005-09-30 | 25.17% |
| 2005-06-30 | -55.31% |
| 2005-03-31 | -62.97% |
| 2004-12-31 | -38.16% |
| 2004-09-30 | -79.10% |
| 2004-06-30 | -315.04% |
| 2004-03-31 | -153.78% |
| 2003-12-31 | -185.93% |
| 2003-09-30 | -351.94% |
| 2003-06-30 | -710.74% |
| 2003-03-31 | -284.72% |
| 2002-12-31 | 271.47% |
| 2002-09-30 | -716.38% |
